DEM BioPharma

Cambridge, United States

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Jun 2022

Series A

Biotechnology Life Science Oncology Pharmaceutical

Top Investors

Insight Venture ManagementLLC.Longwood FundPfizer Venture InvestmentsAlexandria Venture InvestmentsAlta Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DEM BioPharma

Who are DEM BioPharma's investors?

DEM BioPharma's investors include Insight Venture Management, LLC., Longwood Fund, Pfizer Venture Investments, Alexandria Venture Investments, Alta Partners.

Where is DEM BioPharma headquartered?

DEM BioPharma is headquartered in Cambridge, United States.

What does DEM BioPharma do?

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

What stage is DEM BioPharma at?

DEM BioPharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2022.

MLA

"DEM BioPharma — Funding & Investors." VCBacked, June 23, 2022, https://www.vcbacked.co/company/dem-biopharma. Accessed July 1, 2026.

APA

VCBacked. (2022). DEM BioPharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dem-biopharma

Wikipedia (cite web)

{{cite web |title=DEM BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/dem-biopharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2022.